In breast cancer, it has been reported that inhibition of UBE2S or UBE2C suppressed the malignant characteristics of breast cancer cells and sensitized cancer cells to radiation or drugs to enhance clinical effectiveness (11, 16–18). This evidence concerns the gene UBE2S and breast cancer.